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Adipose tissues have striking plasticity, highlighted
by childhood and adult obesity. Using adipose line-
age analyses, smooth muscle actin (SMA)-mural
cell-fate mapping, and conditional PPARg deletion
to block adipocyte differentiation, we find two
phases of adipocyte generation that emanate from
two independent adipose progenitor compartments:
developmental and adult. These two compartments
are sequentially required for organ formation and
maintenance. Although both developmental and
adult progenitors are specified during the develop-
mental period and express PPARg, they have distinct
microanatomical, functional, morphogenetic, and
molecular profiles. Furthermore, the two compart-
ments derive from different lineages; whereas adult
adipose progenitors fate-map from an SMA+ mural
lineage, developmental progenitors do not. Remark-
ably, the adult progenitor compartment appears to
be specified earlier than the developmental cells
and then enters the already developmentally formed
adipose depots. Thus, two distinct cell compart-
ments control adipose organ development and organ
homeostasis, which may provide a discrete thera-
peutic target for childhood and adult obesity.INTRODUCTION
Adipose depots develop in utero and during childhood (Birsoy
et al., 2011; Tang et al., 2008). Once formed, white adipocytes
store triglycerides and produce signals that regulate systemic
metabolism (Rosen and Spiegelman, 2006; Spiegelman and
Flier, 2001). During childhood and adult life, adipose depots
protect against trauma and the cold and control a variety of
processes such as thermoregulation and appetite (Rousseau
et al., 2003). Adipose depots also appear to have adult-specific
roles such as in fecundity, reproduction, and lifespan control
(Hossain et al., 2007; Rosen and Spiegelman, 2006; Schwim-
mer and Haim, 2009; Spiegelman and Flier, 2001). Yet whether
the stem cells that generate the two types of adipocytes, child-Cell Rhood and adult, are related is unknown (Prins and O’Rahilly,
1997). What appears clear is that forming and maintaining a
relatively constant pool of adipocytes is essential for health;
an excess (obesity) or deficit (lipodystrophy) of adipose tissue
leads to metabolic dysfunction (Ailhaud et al., 1992; Gesta
et al., 2007). Several lines of evidence, including human studies,
indicate that new adipocyte formation is a key aspect of adult
homeostatic balance and is required for maintenance and turn-
over throughout life (Faust et al., 1978; Johnson and Hirsch,
1972; Spalding et al., 2008). Further, obesogenic and other
external stimuli appear to change the adipose turnover rate,
and recent studies support the notion that such cues trigger
formation of new adipocytes, possibly from an adipose stem
compartment (Daniels, 2006; Hossain et al., 2007; Kopelman,
2000).
Tissue development and homeostasis often require a steady
replenishment of cells from stem or progenitor sources (Weiss-
man, 2000). These cells typically reside in a niche, a critical
specialized microenvironment that regulates transitions of
stem cells between quiescence, proliferation, and differentia-
tion (Li and Clevers, 2010). Using a lineage marking system
termed AdipoTrak (Tang et al., 2008), we recently began to
identify and characterize a population of adipose progenitors
that appear to have stem function and express PPARg, a mas-
ter regulator of adipocyte differentiation (Chawla et al., 1994;
Tontonoz et al., 1994). For example, AdipoTrak-marked cells
exhibit many canonical stem properties, such as their ability
to self-renew, proliferate, and differentiate into adipocytes. In
AdipoTrak, we recombined the tet-transactivator (tTA; ‘‘Dox
Off’’ system) into the endogenous PPARg locus (PPARgtTA)
and combined this with complementary reporter systems
(e.g., TRE-H2B-GFP; TRE-Cre, R26RlacZ). Although the system
has limited ability to mirror the dynamic expression of endog-
enous PPARg, largely due to the long perdurance of TRE-H2B-
GFP (Kanda et al., 1998) and the indelible marking of R26RlacZ,
AdipoTrak shows predominant adipose-restricted expression
and can be effectively suppressed by doxycycline (Tang
et al., 2008). Using these tools, we found that some
AdipoTrak-marked cells resemble a subset of mural cells and
localize to the perivascular region in established depots, which
we postulated serves as an adipose progenitor cell niche (Tang
et al., 2008). Mural cells, also termed pericytes or vascular
smooth muscle cells denoting their expression of smooth
muscle actin (SMA), reside at the vascular/periendothelialeports 9, 1007–1022, November 6, 2014 ª2014 The Authors 1007
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interface (Armulik et al., 2011). Yet no direct evidence exists
that mural cells or AdipoTrak labeled cells are required for ad-
ipose tissue development or maintenance, and other localities
such as the bone marrow and endothelium have been put forth
as the origin of adipose stem cells (Cai et al., 2011; Crossno
et al., 2006; Dani et al., 1997; Koh et al., 2007; Tran et al.,
2012).
Here, we use the AdipoTrak system coupled with a mural cell-
fate-mapping model (SMA-CreERT2) and conditional PPARg
gene knockouts to investigate adipose lineage dynamics during
both adipose development and adult tissue maintenance. We
find that AdipoTrak-labeled cells appear to be key sources of ad-
ipose progenitors, and there appear to be two distinct
AdipoTrak-marked adipose progenitor compartments, develop-
mental and adult, that give rise to adipocytes during adipose tis-
sue development and homeostasis, respectively. In established
adult adipose depots, adipocytes fate-map from SMA+ progen-
itors residing in the perivascular niche, yet adipocytes from
developing depots do not. Rather, developmental adipose pro-
genitors are required for adipose depot formation and have
distinct microanatomical, functional, and molecular properties
compared to adult progenitors. Of note, the SMA+ adult progen-
itors are required for adult adipose tissue homeostasis and turn-
over; blocking their differentiation using a conditional PPARg
allele with either AdipoTrak or SMA-CreERT2 disrupts adipose
depot structure and function. Interestingly, the adult progenitor
lineage appears to be specified as early as embryonic day 10.5
(E10.5), significantly before the developmental progenitors,
even though the role of the early-specified adult progenitors is
later in life. In support of this notion, deleting PPARgwithin these
E10.5 AdipoTrak cells has no effect on adipose tissue develop-
ment but does disrupt adult depot maintenance. Together, our
data indicate that there are two distinct adipose progenitor com-
partments, developmental and adult, which are essential cellular
components for adipose tissue formation and maintenance,
respectively.
RESULTS
PPARg-Expressing Progenitors Are Essential for
Adipose Tissue Development and Homeostasis
Previous studies show that AdipoTrak (PPARg tTA; TRE-Cre;
TRE-H2B-GFP) cells fate-map into adipocytes during the devel-
opment period and in adults (Tang et al., 2008). To examine the
requirement of the AdipoTrak-labeled progenitor compartment
during both depot formation and maintenance, we used theFigure 1. AdipoTrak-Labeled Adipose Progenitors Are Required for Ad
(A) Experimental design. AdipoTrak-PPARgfl/tTA mice were either maintained con
(Null), or Dox was removed at the 10th or 30th day of life to induce deletion of PPAR
as control.
(B) Body fat content, subcutaneous (SQ) depot weights, and random glucose leve
constitutive deletion (PPARg Null), P10 and P30 Dox off (PPARg mutants); *p < 0
(C) Hematoxylin and eosin (H&E) staining of adipose depots of mice described in
(D) Oil red O staining of adipogencially induced SV cells isolated from the above
(E–G) Experimental design. AdipoTrak-PPARgfl/tTA mice were administered Dox
analyzed fat content, adipose depot weights, and glucose levels; *p < 0.05 versu
(H) Oil red O staining of adipogencially induced SV cells isolated from mice in (E
Data are expressed as mean ± SEM.
Cell RAdipoTrak system to constitutively or conditionally, in a tempo-
rally controlled manner, mutate PPARg (PPARgfl/tTA; TRE-
Cre = AdipoTrak-PPARgfl/tTA) (Ahmadian et al., 2013; Rosen
et al., 1999; Tontonoz et al., 1994; Tontonoz and Spiegelman,
2008), thereby disrupting adipocyte differentiation in AdipoTrak
progenitors (Figure S1A). These experiments are designed not
to address the unequivocal requirement of the PPARg gene in
adipocyte formation but rather to test the potential necessity of
AdipoTrak-labeled progenitors in fat formation and depot main-
tenance. We randomized, before conception, the parents of
AdipoTrak-PPARgfl/tTA mice to vehicle (AdipoTrak on, PPARg
null) or to doxycycline (Dox; which crosses the placenta and is
incorporated into breast milk) suppressing PPARg deletion,
termed E0 for embryonic day 0, which we then continued in co-
horts postweaning. AdipoTrak (PPARgtTA/+; TRE-Cre) served as
controls. At P60, both the AdipoTrak control and AdipoTrak-
PPARgfl/tTA Dox-suppressed mice had normal adiposity, blood
glucose, and tissue morphology (Figures 1B, 1C, and S1B), indi-
cating that Dox suppression of PPARg deletion was effective.
However, PPARg null mice displayed reduced adiposity, small
adipose depots, hyperglycemia, disrupted tissue morphology,
and reduced adipose tissue expression of PPARg and down-
stream targets (Figures 1B, 1C, and S1B). This mutant resembles
PPARg null mice produced by epiblast deletion of PPARg (Duan
et al., 2007; Zeve et al., 2012). A potential caveat of thismethod is
that PPARg null disruption occurred in the AdipoTrak source
before depot establishment, potentially disrupting depot forma-
tion or architecture, effects that might impede, mask, or preclude
function of adipocyte progenitors in homeostatic responses. To
circumvent this limitation and test the potential requirement of
AdipoTrak-labeled progenitors in extant adipose tissue, we
conditionally deleted PPARg in already established depots
with AdipoTrak-PPARgfl/tTA at discrete times during depot devel-
opment and homeostasis. In these studies, PPARg deletion was
Dox suppressed before conception and throughout embryogen-
esis. The Dox-suppressed mice were then randomized to
continual Dox (E0) or Dox was removed at postpartum day 10
(P10; P10 Dox off) or P30 (P30 Dox off), to allow tTA activation,
TRE-Cre expression, and PPARg deletion (Figure 1A). At P60,
both the P10 and the P30 Dox-off mutant mice displayed
reduced adiposity, small adipose depots, hyperglycemia, dis-
rupted tissue morphology, and reduced adipose tissue expres-
sion of PPARg and downstream targets (Figures 1B, 1C, and
S1B). At P60, we also evaluated the cell-autonomous adipogenic
potential of stromal vascular (SV) cells, thought to contain
adipose stem cells, isolated from control, E0 Dox-on, P10ipose Tissue Development and Homeostasis
stitutively on Dox throughout life (suppressed, E0) or not on Dox throughout life
g in AdipoTrak-labeled cells. AdipoTrak (PPARgtTA/+; TRE-Cre) mice were used
ls of AdipoTrak (Con, no Dox), constitutively suppressed mutant (E0, Dox ON),
.05 versus control levels.
(A).
mice at P60. Scale bar, 100 mm.
before conception or Dox was added at P10 or P30 (E) and at P60 mice were
s control levels (F). (G) H&E-stained depots from mice described in (E).
) at P60. Scale bar, 200 mm.
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Dox-off, and P30 Dox-off mutant mice and cultured them in adi-
pogenic media. The mutant cells did not display adipogenic po-
tential based upon appearance, oil red O staining, triglyceride
levels, and gene expression (Figures 1D, S1C, and S1D).
Together, these data indicate that AdipoTrak-labeled progeni-
tors are required for adipose tissue development and
homeostasis.
Next, we attempted to address whether other potential non-
AdipoTrak-labeled stem/progenitor cell sources, newly derived
AdipoTrak or non-AdipoTrak adipocyte, arise after Dox suppres-
sion (stopping PPARg deletion). For this approach, we added
Dox at discrete times during adipose depot formation (P10
Dox on) or during adipose homeostasis (P30Dox on) to suppress
the tTA/TRE-Cre system and then block further deletion of
PPARg in potential new contributing adipose stem cells:
either newly arisen AdipoTrak progenitors (derived from non-
AdipoTrak sources) or possible other non-AdipoTrak sources.
These potential cells should therefore contain a wild-type
PPARg, and if the cells have endogenous adipogenic potential,
they should form or maintain normal depots or they should pro-
duce non-AdipoTrak-marked adipocytes, even when AdipoTrak
progenitor differentiation has been impeded (Figure 1E). At P60,
P10, and P30, Dox-on AdipoTrak-PPARg mutant mice all
showed similar lipodystrophic phenotypes: low body fat, a
paucity of adipose tissue and adipocytes, hyperglycemia, and
reduced expression of PPARg and adipocyte markers (Figures
1F, 1G, and S1E), similar to the PPARg-null phenotype in
Figure 1C.
To examine stem cell-autonomous functions, we isolated SV
cells from depots of these mutant mice and cultured the cells
in Dox (to suppress tTA, thereby blocking any in vitro PPARg
deletion in any new potential sources) and adipogenic condi-
tions. Under these conditions, the SV cells did not differentiate,
indicated by the lack of the oil red O staining, reduced triglycer-
ide levels, and gene expression (Figures 1H, S1F, and S1G).
Together, the data suggest that AdipoTrak-labeled progenitors
are required and appear to be a major source for adipose tissue
development and possibly homeostasis.
Adult Adipocytes Derive from an SMA+ Mural Cell
Source
We previously observed that AdipoTrak-GFP-marked cells
resemble mural cells residing in the perivascular region of
mature adipose depots (Tang et al., 2008). This appearance
and several other indirect studies indicated that the vessel
might serve as an adipose progenitor niche (Cai et al., 2011;
Gupta et al., 2012; Han et al., 2011). Niche residence is a cen-
tral feature of adult stem cells and is often acquired toward the
end of the developmental phase, which for murine depots is in
the first few postpartum weeks. Consistent with that notion, we
found that at earlier stages of adipose organogenesis (P10),
progenitors reside off the blood vessel, but at P30, in already
formed depots, marked cells have occupied mural perivascular
positions (Figure 2A). By P20, the cells appeared juxtaposed to
the vessel, but primarily in nonmural positions with a subset in
the vessel wall per se (Figure 2A). Stromal vascular particulates
(SVP), an organotypic method to study the niche within its
native context (Tang et al., 2008), also show the same adipose1010 Cell Reports 9, 1007–1022, November 6, 2014 ª2014 The Authprogenitor localization: none in the blood vessels at P10, many
at mural positions at P30, and P20 in transition (Figure 2B).
Thus, it appears that during adipose tissue development, Adi-
poTrak-marked cells reside off the vessel, whereas within
mature established adipose tissue, they reside on the blood
vessel.
To determine whether mural cells contribute to adipose tissue
development and/or adipose tissue homeostasis and turnover,
we combined AdipoTrak-GFP marking with a tamoxifen (TM)-
inducible SMA-CreERT2 fate-mapping model using two indepen-
dent indelible Cre reporter lines: R26RlacZ and R26RRFP (Fig-
ure S2A). This system is designed for long-perdurance GFP
adipose lineage marking (PPARgtTA; TRE-H2B-GFP) (Kanda
et al., 1998; Tang et al., 2008), while the Cre-dependent reporters
are intended to label the mural cell lineage and all descendants,
in an indelible fashion (SMA-CreERT2; R26RlacZ = SMA-lacZ or
SMA-CreERT2; R26RRFP = SMA-RFP) (Wendling et al., 2009).
The SMA-CreERT2 fate-mapping model was generated from a
bacterial artificial chromosome construct reported to have
high-fidelity expression (Wendling et al., 2009). We induced
SMA-dependent recombination by providing one dose of TM
on two consecutive days at P10 (organogenesis) or P30 (estab-
lished depots for adipocyte turnover and maintenance) and
examined reporter expression either on the third day (P12 or
P32, pulse) or at P60 (pulse-chase) (Figures 2C, 2D, S2B, and
S2C); siblings that did not receive TM served as controls (Fig-
ure S2D). At the short time frames (P12 or P32, pulse), SMA-
dependent reporter expression (e.g., red fluorescent protein
[RFP], lacZ) was restricted to perivascular mural cells, as re-
ported previously (Armulik et al., 2011; Nehls and Drenckhahn,
1993; Wendling et al., 2009), and mature adipocytes were not
labeled (Figures 2D, S2B, and S2C). During the P10 to P60
pulse-chase, we again observed strong perivascular, without
adipocyte, labeling in subcutaneous (SQ; inguinal, interscapular)
and visceral (Vis, perigonadal, retroperitoneal) depots with either
RFP or LacZ (Figure 2E, top row, and Figure S2E). Yet during the
P30 to P60 pulse-chase, reporter expression evolved with label-
ing of both SQ and Vis depots with either RFP (Figure 2E, bottom
row, and Figure S2E) or lacZ indelible reporters (Figure S2C). The
different fate-mapping observations did not appear to stem from
the elongated pulse-chase protocol of the P10 mice (P10–P60
versus P30–P60), as a P30–P90 chase labeled adipose depots
(Figure S2F). These data support the notion that P30 SMA+ cells
give rise to adipocytes.
During the developmental phase (organogenesis), adipose de-
pots undergo rapid expansion and potentially increase turnover
(Rigamonti et al., 2011; Spalding et al., 2008; Tang et al., 2008).
To examine the possibility that rapid adipose tissue turnover dur-
ing this time frame might obscure SMA fate mapping, we per-
formed a shorter chase (P10–P30), but again SMA+ cells did
not contribute to adipocyte formation (Figure S2G). A P3 to
P30 pulse-chase also generated perivascular labeling, but not
adipocyte fate mapping (data not shown). To examine if these
early SMA-CreERT2-marked cells were utilized later in the adult,
we fate mapped from P10 to P180, but again only the perivascu-
lar region appeared labeled (Figure S2H). However, a P90 to
P120 SMA-CreERT2 chase produced strong depot labeling (Fig-
ure S2I), indicating that SMA+ cells are used as a source ofors
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Figure 2. Adult Adipocytes Derive from a Mural Cell Source
(A) Sections from P10, P20 and P30 AdipoTrak-GFP SQ depots were examined for GFP (green), PECAM (blue), and SMA (red). Scale bar, 100 mm.
(B) GFP fluorescent images of SVPs isolated from P10, P20, and P30 AdipoTrak SQ depots.
(C) Cartoons and schema depicting fate-mapping analysis. SMA-Cre ERT2; R26RRFP are induced with TM for 2 consecutive days at either P10 or P30 and then
analyzed at P12 or P32 or chased to P60.
(D and E) AdipoTrak-GFP (PPARgtTA; TRE-H2B-GFP); SMA-Cre ERT2; R26RRFP mice were administered TM at P10 or P30 for 2 consecutive days, and SQ
(inguinal) and Vis (perigonadal) adipose depots were examined for GFP (adipose lineage) and RFP (mural lineage) fluorescence either at pulse (P10–P12 or P30–
P32) (D) or chase (P10–P60 or P30–P60) (E). See Figure S2A for experimental genotypes. Scale bar, 100 mm.
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progenitors for adipocytes throughout the adult depot life cycle,
but not during depot organogenesis.
Developmental and Adult Adipose Progenitors
To dissect the cellular basis of the lineage specification, we next
examined adipose tissue sections from AdipoTrak-GFP; SMA-
RFPmice (GFPmarks adipose lineage, RFPmarksmural lineage
and descendants) pulsed with TM at P10 or P30 and chased to
P60. The P30 initiated pulse-chase specimens displayed RFP+
unilocular adipocytes that immunostained with Perilipin, an
adipocyte marker, and costained with LipidTox, but the P10
samples did not (Figures 3A and 3B). Quantification indicated
that about 25% of all adipocytes were labeled by the SMA-
CreERT2 system between P30 and P60, a proportion that aligns
with previous studies of percentages of adipocytes labeled
over this period (data not shown) (Tang et al., 2011). During
this 30-day chase, we also visualized RFP signal in floating
P30–P60 pulse-chase adipocytes, isolated by density centrifu-
gation, but not in P10–P60 adipocytes (Figure 3C). We next
examined the in vitro adipogenic potential of P10 and P30 TM-
pulsed SMA-RFP SV cells, containing both SMA+ and SMA
cells. Although the SV fraction from either P12 or P32 appeared
equally adipogenic, based upon oil red O staining, gene expres-
sion and triglyceride quantification (Figures 3D, S3A, and S3B),
only P32 SV cells produced RFP+ adipocytes (Figure 3E), indi-
cating that they derived from an SMA lineage. Further, the brief
TM pulse labeled >75% of the SV-formed adipocytes (not
shown). Together, these data indicate that at least a subset of
mural cells function as adipose progenitors for depot mainte-
nance and also support the possibility that adipose organogen-
esis derives from a distinct source.
We next assessed the specificity of SMA-CreERT2 labeling,
especially at P30, when the marked cells have acquired adipose
progenitor function. As a step, we examined histological speci-
mens of P12 or P32 AdipoTrak; SMA-RFP depots after either a
P10 or P30 TM pulse, respectively. We found that robust RFP
expression aligned in mural positions on depot vasculature
that coimmunostained with multiple mural markers such as
SMA, NG2, and PDGF-Rb, but not with endothelial markers
(e.g., PECAM) (Figures 3F and S3D–S3F), as reported previously
(Armulik et al., 2011). Consistent with this, flow cytometric
studies showed that the vast majority of RFP+ cells costained
with SMA, indicating high correspondence to endogenous
expression (Figures 3G and S3C). Other well-established mural
markers were also expressed on the majority of RFP+ cells;
approximately 75% of the RFP+ cells expressed NG2 and
PDGF-Rb (Figure 3G). Cell-surface phenotyping also showed
coexpression of several proposed adipose stem cell markers:
the majority of the RFP-marked cells expressed Sca1 and
CD24, and about half expressed CD34 and PDGF-Ra (Fig-
ure 3G). Furthermore, quantitative PCR analyses of flow-sorted
SMA-driven RFP+ SV cells compared to flow-sorted RFP cells
showed that SMA-traced cells had significant enrichment of
PPARg and Zfp423, an adipose progenitor marker (Gupta
et al., 2010), and a battery of mural cell markers; RFP cells
were enriched in endothelial marker expression (Figure 3H). In
agreement with previous reports, SMA-dependent reporters
also marked mural cells of vessels in other organs (Figures1012 Cell Reports 9, 1007–1022, November 6, 2014 ª2014 The AuthS3G–S3I) (Wendling et al., 2009). Together, these data indicate
that the SMA-Cre ERT2 marking system has high fidelity and the
expected specificity: SMA-dependent reporters are expressed
in mural microanatomic positions, and their genetic signature
resonates with mural profiles.
Morphogenetic Properties of Developmental and Adult
Adipose Progenitors
To examine the possibility of two adipose progenitor sources/
compartments, we employed our AdipoTrak-GFP; SMA-RFP
mice, which allow independent, and comparative, analyses of
the adipose lineage (GFP+) and the mural lineage (RFP+). Flow
cytometric quantification indicated that many P30 AdipoTrak-
GFP-positive SV cells colabeled with RFP, but P10 GFP+ cells
did not (Figure S4A). Similarly, P30 SMA-RFP-positive SV cells
colabeled with GFP, but P10 RFP+ cells did not (Figure S4B). An-
alyses of TM-pulsed P10–P12 and P30–P32 adipose sections
indicated that P10 GFP+ adipose progenitors did not reside at
the vascular interface, whereas P30 GFP+ adipose progenitors
did (Figure 4A). SVPs also showed the same adipose progenitor
cell pattern: GFPmarked stem cells that costained with RFP pre-
sent in blood vessels at P30, but not at P10 (Figure 4B). These
distinguishable features (e.g., microanatomic and fate-mapping)
prompted us to refer to ‘‘developmental’’ adipose progenitors
and ‘‘adult’’ adipose progenitors, as they might be different cell
types.
To test whether the difference in niche localization of the
developmental and adult adipose progenitors might be due to
inherent morphogenetic properties, we assessed several
explant, in vitro, and molecular correlates. To explore vasculo-
genic and nichegenic potential, we explanted portions of P10,
P20, and P30 AdipoTrak-GFP depots, encased them in Matri-
gel, and monitored the explants for vascular outgrowths (Gea-
lekman et al., 2008; Han et al., 2011). All explants produced
capillary outgrowths; however, the P30 depots had longer and
denser vascular sprouts and higher GFP+ progenitor cell occu-
pancy, whereas the P20 depots had an intermediate phenotype
(Figures 4C, 4F, and 4G). Next, we examined the migratory po-
tential of fluorescence-activated cell sorting (FACS)-isolated
GFP+ developmental and adult adipose progenitors in a
scratch-motility assay. We found that P20 and P30 progenitors
had higher migratory rates than P10 progenitors; P30 cells had
the highest motility (Figures 4D and H). We also utilized trans-
well plate and modified Boyden chamber assays (Chen,
2005), first monitoring the ability of FACS-isolated GFP+ adi-
pose progenitors to move from one chamber to another. We
again observed the same trend: P10 cells with the lowest migra-
tion, P20 cells in the middle, and P30 progenitors showing the
greatest potential (Figures 4E and 4I). We next probed the pos-
sibility that SV cells, containing endothelial and other cells that
constitute the niche, might alter adipose progenitor movement.
For this, we placed FACS-isolated P10 and P30 GFP+ progen-
itors in one chamber and age-matched SV cells in the other. We
also performed reciprocal migration assays with age-mis-
matched SV cells: P10 adipose progenitors with P30 SV cells,
and P30 progenitors with P10 SV compartment. We found
that P10 progenitors had an overall lower migratory potential
that appeared unaffected by either SV compartment (Figure 4J).ors
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(A–C) AdipoTrak-GFP; SMA-RFP mice were administered TM at P10 or P30 and chased to P60. (A) Sectioned SQ depots were analyzed for RFP and immu-
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stained (D) or examined for RFP fluorescence (E). Yellow arrows (E) indicate SMA-RFP-labeled adipocytes.
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arrows indicate AdipoTrak-GFP; SMA-RFP-labeled progenitors in a perivascular position at P30.
(G and H) FACS analyses (G) and mRNA analyses (H) of denoted genes in FACS-isolated RFP+ or RFP cells from SMA-RFP mice 2 days post TM injection.
*p < 0.01 RFP+ versus RFP cells. Scale bar, 100 mm.
Data are expressed as mean ± SEM.Notably, the potential of the P30 progenitors to migrate was
stimulated by age-matched SV cells, whereas the P10 SV cells
inhibited P30 progenitor migration (Figure 4J). Molecular ana-Cell Rlyses supported the functional tests: FACS-isolated adult adi-
pose progenitors (P30) had significantly higher levels of mural
cell (e.g., SMA, PDGF-Rß, and NG2) and vasculogenic (e.g.,eports 9, 1007–1022, November 6, 2014 ª2014 The Authors 1013
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Figure 4. Functional andMolecular Charac-
teristics of Developmental and Adult
Adipose Progenitors
(A and B) RFP and GFP images of sectioned SQ
depots from TM pulsed (P10–P12, P30–P32) Adi-
poTrak-GFP; SMA-RFP mice. Scale bar, 200 mm.
(B) SVPs were isolated from the above mice (A)
and examined for RFP and GFP expression and
counter stained with DAPI (nuclear, blue).
(C, F, and G) P10, P20, and P30 AdipoTrak SQ
depots were encased in Matrigel, and 7 days later,
capillary outgrowth was assessed with pseudo-
Nomarski microscopy (C), length quantification
(F), and GFP+ stem cell occupancy (G).
(D and H) P10, P20 or P30 AdipoTrak FACS-iso-
lated GFP SV cells were cultured to confluence
and scratched, and migration was visualized (D)
and quantified (H).
(E and I) P10, P20, or P30 AdipoTrak FACS-iso-
lated GFP+ SV cells were placed in a modified
Boyden chamber. Transwell migration was
imaged 12 hr later (C) and quantified (G).
(J) P10 and P30 FACS-isolated GFP+ cells were
placed in one chamber and no cells (), P10, or
P30 SV cells in the other. GFP cell transwell
migration was quantified 12 hr later. **p < 0.05
versus P30 stem cell migration without SV cells.
(K) Quantitative PCR expression analyses of P10
or P30 FACS-isolated GFP+ SV cells.
For (F)–(K), *p < 0.05 versus P10 stem cells.VEGF-A) markers, which were low or undetectable in isolated
developmental adipose progenitors (P10) (Figure 4K). Flow cy-
tometric studies also showed an enrichment of mural markers1014 Cell Reports 9, 1007–1022, November 6, 2014 ª2014 The Authorsin P30 AdipoTrak-marked progenitors,
with the majority of GFP+ cells coex-
pressing mural markers, and that coex-
pression of a variety of proposed adi-
pose progenitor markers such as CD34,
SCA1, CD24, and PDGF-Ra were similar
in developmental and adult progenitor
populations (Figures 4K and S4B). Taken
together, the data indicate that adult
adipose progenitors have distinct func-
tional properties and molecular profiles
compared to developmental adipose
progenitors, and that might account for
their different niche localities.
Mural Resident Progenitors
Contribute to Adipose Depot
Homeostasis
The AdipoTrak PPARg deletion studies
indicated a required role of the
AdipoTrak-marked progenitors in both
adipose depot organogenesis and ho-
meostasis (Figure 1). However, the dis-
torted depot architecture that results
from early or late loss of PPARg might
preclude stem function of potential newstem cells in the Dox-on studies, possibly even in the isolated
stromal vascular fraction (SVF) setting. Further, expression of
AdipoTrak throughout the adipose lineage (stem cells to
adipocytes) or in other cell types may confound the Dox-off an-
alyses. For example, AdipoTrak-induced deletion of PPARg in
extant adipocytes might change the character of the depot
even in the absence of changes in stem cell function. To probe
the specific contribution of mural-resident adult adipose progen-
itors, we conditionally deleted PPARg with the SMA-CreERT2
mural cell driver (SMA-CreERT2, PPARgfl/fl = SMA-PPARg) that
appears to be specific to the progenitors and is not expressed
in adipocytes per se at pulse but does fate-map into adipocytes
thereafter. We induced PPARg deletion by administering one
dose of TM on two consecutive days starting at P30, a time
when SMA+AdipoTrak+ cells are present in themural perivascu-
lar niche. As a control, we also induced SMA-dependent deletion
at P10 when SMA-negative, nonmural resident AdipoTrak+
developmental adipose progenitors are present. We analyzed
the adipose phenotypes 4 weeks later (Figures 5A and S5A).
Consistent with the SMA fate-mapping studies (Figures 2 and
3), we observed no significant adipose phenotypes when PPARg
was deleted within the SMA lineage at P10; body fat content, ad-
ipose tissue size, histology, fed glucose, sera triglycerides, adi-
pose gene expression, and glucose tolerance were similar to
controls (Figures 5B, 5D, 5E, S5B, S5C, and S5F). In contrast,
deletion of PPARg in P30 SMA+ cells resulted in reduced fat con-
tent (similar to their initial fat content), smaller depots with
aberrant histology, hypertriglyceridemia, and altered adipose
molecular profile and glucose intolerance (Figures 5C–5E and
S5D–S5F). To track progenitor autonomous functions, we also
SMA-CreERT2 fate mapped in the setting of PPARg disruption.
Notably, P30 PPARg-null SMA+ cells did not give rise to RFP+
adipocytes, resembling the lack of SMA-RFP adipocyte fate
mapping of P10 mice, whereas control P30 SMA+ cells express-
ing PPARg did (Figure 5G).
The fate-mapping data supported a progenitor-specific
defect, but PPARg may also have roles in SMA vascular cell
function that could affect depot integrity. To assess this possibil-
ity, we quantified whole depot expression of several vascular
markers (e.g., SMA,NG2, PDGF-Ra, and PECAM) in either dele-
tion setting, yet the levels appeared unchanged (Figure 5E). We
also histologically examined other organ systems and found no
histological differences when SMA-PPARg deletion was
induced at either P10 or P30 (Figures 5F and S5G). Further, there
was no evidence of vascular changes or vascular leakage in
these organs or in depots (Figures 5F and S5G, data not shown).
Thus, deleting PPARg in P10 and P30 SMA+ cells produce
similar vascular phenotypes between P10 and P30 chases, indi-
cating that vascular dysfunction is unlikely to be the primary insti-
gator of adipose tissue effects.
To further evaluate potential cell autonomy (that is, progen-
itor-specific effects), we repeated the P10 and P30 TM pulses,
collected SVF at P12 and P32, and cultured the cells in adipo-
genic conditions. The adipogenic potential of P10-pulsed SV
cells appeared normal; in contrast, the P30 mutant SVF failed
to differentiate indicated by the lack of the oil red O staining
and reduced adipocyte marker expression (Figures 5H and
S5H). We also examined potential cell autonomy by isolating
P30 SV cells from uninduced SMA-PPARg mice, ie, from de-
pots that are unaffected and have normal vasculature and
depot integrity. We then cultured the cells in adipogenic mediaCell Rcontaining either vehicle or TM. Within 48 hr of TM addition to
induce SMA-PPARg deletion in cell culture, PPARg expression
was reduced, yet levels of vascular markers (SMA, NG2,
PDGF-Ra, and PECAM) were unchanged (Figure S5I). Consis-
tent with the reduction in PPARg expression, SV cells from
SMA-PPARg mice that received TM did not undergo adipocyte
differentiation, whereas vehicle-treated cells underwent adipo-
genesis as indicated by adipocyte marker expression (Fig-
ure S5J). Together, the SMA-PPARg genetic models provide
in vivo and in vitro functional and molecular support for
the notion that mural cells act as adipose progenitors, but
only in established adult depots and not during adipose
development.
Adult Adipose Progenitors Are Specified Earlier than
Developmental Progenitors
Next, we attempted to unravel the lineage relationship between
the developmental and adult progenitors, exploring whether
developmental progenitors might evolve into adult progenitors
or whether the two progenitor compartments might have inde-
pendent origin. To delineate the temporal pattern of adipose
lineage specification, we combined AdipoTrak with R26RlacZ
(AdipoTrak-lacZ = PPARg+/tTA; TRE-Cre; R26RlacZ) to indelibly
label adipose progenitors. We treated cohorts of AdipoTrak-
lacZ mice with placebo or Dox to suppress tTA activity, thereby
blocking any new lacZ expression. We added Dox at regular in-
tervals during embryogenesis and in the peripartum period
when adipose organogenesis occurs. We then analyzed all
offspring for lacZ expression at P30, when depots are already
established and the adult progenitors have occupied niche po-
sitions (Figures 2 and 3). In this situation, adipose progenitors
will be indelibly labeled by b-galactosidase only if the stem
compartment was specified prior to Dox addition, evolved,
and underwent adipogenesis. This can be visualized in whole-
mount stains: adipocytes and depots become blue (Xgal+).
We found that specification occurred in a defined sequence:
SQ adipose developmental progenitor (inguinal and interscapu-
lar) marking began about E14.5 and was completed by P2,
retroperitoneal developmental progenitor marking started by
E18.5 and was completed by P4, perigondal developmental
progenitor marking began as early as P4 and continued until
P10, and mesenteric adipose depot developmental progenitor
marking was apparent at P15 and continued until P20
(Figure 6A).
To determine when the adult progenitor cell compartment was
specified, we examined histological sections of the just-
described depots for the presence of lacZ+ cells within the
vasculature. First, we analyzed the vessels of depots in which
the developmental lineage had been specified as indicated by
blue adipocytes in the whole-mount setting (e.g., inguinal with
Dox added from E14.5 on, PGW after P6 Dox, etc.). All harbored
AdipoTrak-lacZ lineage-positive cells in the vessel, indicating
that both developmental and adult progenitor compartments
had been specified (Figure S6A, bottom). Remarkably, even
when we examined depots that were whole-mount lacZ negative
(i.e., Dox was added before developmental progenitor specifica-
tion/marking), we observed AdipoTrak-lacZ-positive cells lining
the blood vessels. For example, E16.5 +Dox retroperitonealeports 9, 1007–1022, November 6, 2014 ª2014 The Authors 1015
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(H) SV cells were isolated 2 days after TM injection and cultured in adipogenic media, and adipogenic potential was assessed by oil red O staining.
Data are expressed as mean ± SEM.white adipose tissue depots show perivascular mural lacZ
marking without adipocyte staining, and these mural resident
lacZ+ cells were PECAM negative (Figure S6A, top). These1016 Cell Reports 9, 1007–1022, November 6, 2014 ª2014 The Authdata support the unexpected possibility that the adult adipose
progenitor compartment is specified prior to the developmental
compartment.ors
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Figure 6. Temporal Course of AdipoTrak Labeling of Adipose Progenitors
(A) AdipoTrak, R26RlacZ mice were Dox suppressed at the denoted times, and each adipose depot was analyzed at P30 for b-galactosidase activity.
(B and C) AdipoTrak, R26RlacZ mice were Dox suppressed at the indicated times (E0 = preconception, or E10.5) and SQ depots (B) examined at P5, P30, or P120
or perigonal adipose depot (C) examined at P30 or P120 for b-galactosidase activity.
(D) AdipoTrak, R26RlacZ mice were Dox suppressed from E0 to P30 (control) or from E10.5 to P5, P30, and P120, and adipose depots were stained with X-gal,
sectioned, and stained with nuclear fast red. Arrows indicate AdipoTrak cells that were marked by E10.5 and present in adult adipose depot vessels; arrowheads
indicate X-gal-labeled adipocytes that derived from cells marked by E10.5.
(E) Immunofluorescence images of adipose depot sections of AdipoTrak R26RRFP mice that were Dox suppressed from E10.5 to P60 and visualized for RFP
(AdipoTrak lineage) and costained with either PECAM or LipidTox (green) and Perilipin or SMA (blue). Scale bar, 200 mm.
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To begin to probe when the adult compartment was first
marked by AdipoTrak, we examined a series of postimplantation
embryos for GFP expression using AdipoTrak-GFPmice. Prior to
E9.5, we did not detect GFP expression (data not shown). Yet by
E10.5, a small number of GFP+ cells were present in the anterior
region of the embryo in the vicinity of developing nervous sys-
tem, neural crest, and notochord (Figure S6B). This pattern ap-
peared to expand and elaborate, with cells appearing in a rostral
to caudal migratory stream over the ensuing embryonic days
(Figures S6B–S6E).
To assess whether some of these embryonically marked cells
might fate-map into vascular-resident adult adipose progenitors,
we returned to the AdipoTrak-R26RlacZ indelible-labeling model.
We also ingressed the R26RRFP reporter, described above in
the SMA tracking system, and generated AdipoTrak-RFP
(PPARg+/tTA; TRE-Cre; R26RRFP) cohorts in part to ease scoring
with direct fluorescence. We provided AdipoTrak-lacZ and
AdipoTrak-RFP cohorts with either vehicle or Dox, to block any
further de novo marking, at E10.5, the developmental stage in
which we observed anterior GFP staining and before any devel-
opmental progenitors are specified. We then assessed potential
adipose-depot fate mapping at P5, P30, P60, and P120 (Fig-
ure S6F). We observed E10.5 adipocyte fate mapping for both
reporters, R26RRFP and R26RlacZ, by P60, but not at P5 or P30
(Figures 6B–6E, S6G, and S6H). However, we did observed
E10.5 AdipoTrak fate mapping onto vessels at P30, but not at
P5 (Figures 6D, S6G, and S6H), consistent with the data set
examining whole mounts for developmental specification (Fig-
ures 6B and 6C). That is, P30, but not P5, blood vessels harbor
marked cells that originated from an E10.5 AdipoTrak+ source.
These P30 RFP-labeled cells, which derive from the E10.5
AdipoTrak source, reside in the mural compartment (SMA+,
PECAM) of blood vessels and by P60 appear to evolve into
RFP-marked adipocytes (Figures 6D and 6E). In the E10.5-P30
fate-mapping studies, the vast majority of adipocytes did not
derive from adult progenitors; that is, they are LipidTox and Peril-
ipin positive but RFP or lacZ negative, indicating that these adi-
pocytes derived from the developmental progenitors as
observed in our earlier fate-mapping studies (Figures 6E and
S6H). In some instances, at P30, we did detect a few
AdipoTrak-RFP-positive adipocytes located in juxtavascular po-
sitions, indicating that adult progenitor cell adipogenesis had
begun (not shown). To see if additional adipocytes derive from
the E10.5-marked cells, we examined depots after longer chase
periods. At P60 and P120 chase points, we detected robust
adipocyte marking with either the AdipoTrak RFP or lacZ re-
porter systems (Figure 6B-E), mirroring SMA-CreERT2 fate-map-
ping data (Figures 2 and 3). These AdipoTrak lineage-marked
unilocular adipocytes coexpress Perilipin and are stained by
LipidTox, indicating that E10.5 AdipoTrak-marked cells fate-
map first into the adipose vasculature, acquire SMA expression,
and then the marked adult progenitors differentiate into adipo-
cytes (Figure 6E, bottom row). To confirm whether the E10.5
adult progenitors expresses PPARg andGFP, we FACS-isolated
GFP+ cells from E10.5 embryos and measured mRNA expres-
sion. We found that PPARg and GFP were preferentially ex-
pressed in the AdipoTrak-marked cells compared to other em-
bryonic cells (Figure S7A), supporting the notion that PPARg1018 Cell Reports 9, 1007–1022, November 6, 2014 ª2014 The Authand AdipoTrak are indeed expressed and that the AdipoTrak la-
beling system has high-fidelity marking, as previously reported
(Tang et al., 2008, 2011; Zeve et al., 2012).
Adult AdipoTrak-Labeled Progenitors Are Required for
Adult Adipose Tissue Homeostasis
The lineage-tracing data indicate that E10.5 AdipoTrak-labeled
embryonic cells generate mural perivascular adult progenitors
that are used in established/mature adult adipose depots, but
not during adipose tissue development. To rigorously explore
that notion and also the possibility that the E10.5 AdipoTrak-
labeled cells are necessary for adult adipose tissue homeosta-
sis, but not adipose tissue development, we again exploited
the AdipoTrak-PPARg genetic configuration. In these studies,
we Dox suppressed AdipoTrak-PPARg mice before conception
(E0, control) or from E10.5 onward (only deleting PPARg in the
adult progenitor pool and not in developmental progenitors,
mature adipocytes, etc.) and monitored adipose depot develop-
ment at P30 or analyzed adult adipose tissue homeostasis
over the subsequent 4 months (Figure 7A). The E10.5 + Dox
AdipoTrak-PPARgmice were born at appropriate Mendelian ra-
tios, and pre- and postpartum studies indicated that the E10.5
AdipoTrak PPARg deletion had no gross effect on tissue devel-
opment (not shown). At P30, the E10.5 + Dox AdipoTrak-PPARg
mice had similar food intake, body weight, and fat content,
although there might be a trend toward increased adiposity (Fig-
ures 7B, S7B, and S7C). Histological, molecular, and cell culture
studies indicated that the P30 depots were relatively unaffected,
with normal adipose depot architecture, normal levels of mature
adipocyte markers, and normal adipogenic potential (Figures
S7D–S7H). The P30 analyses indicate that mice in which
AdipoTrak-PPARg deletion was blocked by E10.5 and thereafter
have apparently normal adipose depot development.
We continued to assess the E10.5 AdipoTrak-PPARg cohort;
over the ensuing months, we observed a decrease in fat content,
while controls continued to increase fat mass (Figure 7B). By
5 months of age, the E10.5 AdipoTrak-PPARgmice had approx-
imately half the body fat as at P30 and were significantly leaner
and had smaller adipose depots than 5-month-old littermate
controls (Figures 7B–7D). Histological studies indicated that
the mutants also had reduced adipocyte size; however, adipose
depot architecture remained intact (Figure 7E). Even though
these mice were lean and had small adipocytes (presumably
derived from developmental progenitors), which are both typi-
cally associated with positive metabolic outcomes, the E10.5 +
Dox AdipoTrak-PPARg mice rather had metabolic dysfunctions
often associated with dysfunctional obese or lipodystrophic ad-
ipocytes, glucose intolerance, and hypertriglyceridemia (Figures
7F and S7I). Expression analyses of adipose depots revealed
reduced levels of mature adipocyte markers including PPARg
in the absence of changes in mural or endothelial cell marker
expression (Figures 7G and 7H), resonatingwith our previous ob-
servations of SMA-PPARg mutant mice (Figure 5). To evaluate
potential cell-autonomous effects, we isolated SV cells from
5-month-old control and E10.5 + Dox AdipoTrak-PPARg litter-
mates. Although control SVF underwent adipogenesis and pro-
duced lipid-storing cells that expressed a host of adipocyte
markers, the mutant SVF failed to differentiate (Figures 7I andors
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Figure 7. Adult Adipose Progenitors Are
Essential for Adipose Depot Homeostasis
and Maintenance
(A) Experimental design. AdipoTrak PPARgfl/tTA
mice were Dox suppressed prior to conception
(E0 = control) or E10.5 and analyzed at P30 or
P150 (5 months). Below: cartoon prediction, illus-
trating that adult adipose are specified and PPARg
deleted by E10.5 and fail to maintain adult adipose
depots.
(B–E) AdipoTrak-PPARgfl/tTA mice were Dox sup-
pressed before conception (E0 = control) or from
E10.5. Mice weremaintained on Dox and analyzed
at P150 (5 months of age) for body fat content
(B), SQ depot size (C), tissue weights (D), and
histology (E).
(F) Control and E10.5 Dox-suppressed AdipoTrak-
PPARgfl/tTA mice at 5 months (P150) of age were
analyzed for glucose sensitivity by a glucose
tolerance test.
(G and H) mRNA expression of mature adipocyte
markers (G) or mural and endothelial cell markers
(H) from SQ depots of control and E10.5 Dox-
suppressed AdipoTrak-PPARgfl/tTA mice.
(I and J) SV cells were isolated from 5-month-old
control or E10.5 PPARg deleted mice and cultured
in adipogenic media and monitored for differenti-
ation by oil red O staining (I) andmRNA expression
of mature adipocyte markers (J). *p < 0.05 E10.5
PPARg versus control (n = 4/group). Scale bar,
100 mm.
Data are expressed as mean ± SEM.
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7J). These data support the E10.5 fate-mapping studies and indi-
cate that deleting PPARg in adult adipose progenitors before
E10.5 results in normal adipose tissue development and function
(at P30); however, adult adipose depots seem unable to properly
maintain homeostasis, turnover, and metabolic control.
DISCUSSION
Several lines of evidence indicate that adipose stem cells are key
elements for adipose depot formation, maintenance, and expan-
sion in response to various stimuli (Berry et al., 2013; Gesta et al.,
2007; Rodeheffer et al., 2008; Tang et al., 2008, 2011). Here, we
combined fate-mapping methodologies and conditional
blockade of adipocyte differentiation to investigate the adipose
lineage and potential physiological contribution of adipose
stem cells to depot development and/or maintenance. Our re-
sults indicate that there are two progenitor populations that
give rise to adipocytes: developmental progenitors for adipose
organogenesis and adult progenitors for adipose homeostasis.
Both progenitor compartments express PPARg and produce ad-
ipocytes yet have distinct functional and molecular properties
and even reside in distinct anatomical niche localities. The two
compartments also appear to arise from independent lineages
and have distinct spatial and temporal patterns of specification.
Both compartments are specified during embryogenesis, yet the
adult progenitors appear to be marked even earlier than Devel-
opmental progenitors, even though they function later in adult
adipose tissue homeostasis. Recent important studies by Hudak
et al. (2014), using a novel Pref-1-GFP-dT transgenic cell killing
strategy, support these notions and reinforce the idea of an
early-formed (E10.5) adult compartment. The Pref-1-marked
cells appear to overlap with those cells identified by the
AdipoTrak fate-mapping tools. Yet the Pref-1 studies did not
distinguish the temporal relationship of specification of the
developmental and adult pools (Hudak et al., 2014). It is formally
possible that developmental and adult progenitors share a prox-
imate common, PPARg (AdipoTrak)-negative, cellular origin that
arises after node formation, streak elongation, germ-layer induc-
tion, and patterning. Such a putative cellular origin must then
subsequently diverge and express PPARg with quite different
temporal, both embryonic and postnatal, and spatial patterns.
Given the temporal proximity to somitogenesis, the spatial prox-
imity to inductive signaling centers, and the quantity and pattern
of appearance, we favor independent lineage derivation. How-
ever, additional studies, such as generating new fate-mapping
models, are likely required. We do find that the E10.5 cells ex-
press both PPARg and GFP, indicating that the reports have
fidelity to endogenous expression and that molecular profiling
might provide relevant targets for such new fate-mapping tools.
The notion of distinct progenitor compartments for organo-
genesis and homeostasis resonates with various other stem
cell lineages such as neural, hematopoietic, and intestinal (Ford-
ham et al., 2013; Li et al., 2013; Pietras and Passegue´, 2013). In
these lineages, stem cells that control either developmental or
adult homeostasis have important molecular, anatomical, and
functional differences and reside in different niche localities
(Copley and Eaves, 2013; Knapp and Eaves, 2014; Pietras and
Passegue´, 2013). For example, some adult hematopoietic stem1020 Cell Reports 9, 1007–1022, November 6, 2014 ª2014 The Authcells (HSCs) reside in a perivascular niche, but the two types of
embryonic HSCs, primitive and developmental, do not (Copley
and Eaves, 2013). Further, adult HSCs are also first specified
early in embryogenesis, between E7.5 and E10.5, near the
aorta-gonad-mesonepheros and placenta and eventually
migrate and inhabit the adult bone marrow cavity, where they
maintain and regenerate blood (Morrison and Scadden, 2014).
The findings that various stem cell systems contain distinct
developmental and adult stem compartments may hint at a gen-
eral principle for organogenesis and homeostasis. It is also
possible that distinct stem cell populations—proliferative devel-
opmental stem cells required for organogenic expansion and
quiescent adult stem cells designed with preservation of the
stem compartment as a key goal—may also be important to pro-
tect genomic integrity of the adult stem compartment. The two
compartments may have distinct evolutionary history, which
could account for the different attributes and timing and location
of specification (Lo´pez-Otı´n et al., 2013). The observation that
during organogenesis, adipose depots are marked in an ordered
temporal pattern, SQ organs first and Vis depots latter, supports
the possibility that developmental progenitor compartments
may themselves derive from different anlagen increasing devel-
opmental progenitor pool diversity, consistent with previous
publications on adipocyte diversity (Berry and Rodeheffer,
2013; Lee et al., 2012; Sanchez-Gurmaches et al., 2012). Such
independent stem compartments, developmental and adult,
may generate cells geared to distinct functions; for instance, in
the adipose system, developmental adipocytes may be de-
signed with a focus on thermoregulation, while the adult lineage
may be a bit more tuned to metabolic homeostasis.
Childhood and adult obesity may have unique attributes that
could be accounted for by distinct adipose stem compartments.
Human prospective and retrospective studies indicate that adi-
posemass and adipocyte number are primarily determined quite
early in life, during embryogenesis and childhood (Cunningham
et al., 2014; Dietz, 1997; Whitaker et al., 1997). This supports
the possibility that developmental progenitors establish an
adiposity set point, which is then fine-tuned by adult progenitors.
Further studies aimed at manipulating developmental and adult
stem cell number may help clarify the roles of the different pro-
genitors in defining adiposity and adipocyte number.
Collectively, these data indicate that there are different func-
tional attributes for adipose progenitor compartments during ad-
ipose tissue formation and homeostasis. The identification of the
two types of adipose progenitor pools, of the transition of adult
progenitors onto a perivascular position, and of their key roles
in depot formation and maintenance may provide therapeutic
entry points to address the epidemics of both childhood and
adult obesity and the subsequent various negative metabolic
derangements.
EXPERIMENTAL PROCEDURES
Animals
AdipoTrak (PPARgtTA; TRE-H2B-GFP; TRE-Cre, R26RlacZ) mice were previ-
ously established in our lab (Tang et al., 2008, 2011; Zeve et al., 2012). PPARg
floxed allele and reporter lines R26RRFP/lacZ are available in The Jackson Lab-
oratory. SMA-CreERT2 was generously provided by Dr. Pierre Chambon. Cre
recombination was induced by administering TM dissolved in sunflower oilors
(Sigma, 300 mg/kg intraperitoneal injection) on 2 consecutive days. Doxycy-
cline (0.5 mg/ml in 1% sucrose) was provided in the drinking water and pro-
tected from light, and it was changed every 2–3 days. All animals were main-
tained under the guidelines of the U.T. Southwestern Medical Center Animal
Care and Use Committee according to NIH guidelines under animal protocol
2010-0015.
Migration Assay
FACS-isolated GFP adipose stem cells were plated and grown to conflu-
ence. Once confluent, a scratch was made using a 200 ml pipette tip. Cells
were washed three times with 1X PBS and photographed. Dulbecco’s modi-
fied Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) was added, and migration was monitored and photographed 8 hr
later. Alternatively, FACS-isolated GFP SV cells were plated in the bottom
of a transwell dish and GFP+ adipose stem cells were plated in the upper
chamber, and migration was monitored and photographed 12 hr later. Addi-
tionally, FACS-isolated GFP+ adipose stem cells were plated in the top of a
transwell dish, and migration was monitored 12 hr later (Chen, 2005). Ten
images were taken from each experimental parameter counted and
averaged.
Adipose Explant Assay
Chopped (30–50 mg pieces) SQ fat depots (Gealekman et al., 2008) were
washed 1X PBS. Pieces were encased in growth factor-free Matrigel (BD
Bioscience). DMEMmedia supplementedwith 10%FBSwas added to the cul-
ture and outgrowths were photographed 7 days later. Progenitor cell occu-
pancy was measured by counting the number of GFP+ cells/capillary
sprouts/image after merging the fluorescence and phase images. A total of
ten images from three explants from three individual mice were measured us-
ing Image J.
Statistical Analysis
Statistical significance was assessed by the two-tailed Student’s t test. Error
bars indicate SEM.
Additional methods are provided in the Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
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and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2014.09.049.
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